Amer Zeidan: So excited to see this meeting materialize after months of work to advance care of patients and research of hematologic malignancies in Middle East SOHOMENA 1st annual meeting.

Quoting Amer Zeidan on X/Twitter:

“So excited to see this meeting materialize after months of work to advance care of patients and research of hematologic malignancies in Middle East SOHOMENA 1st annual meeting. Many thanks to those who helped make it happen & what an absolute pleasure to be one of the co-chairs.”

Source: Amer Zeidan/Twitter.

Amer Zeidan is an Associate Professor of Medicine (Hematology) at Yale University. He is also the medical director of Hematology Early Therapeutics Research, the leader of the Myeloid Malignancies DART (Disease Aligned Research Team), and the director of Continuing Medical Education (CME) at the Hematology division and chairs the Protocol Review Committee (PRC) at Yale Cancer Center. Dr. Zeidan is a well-known leukemia researcher with a special focus on targeted therapies and immunotherapy for myeloid malignancies, and a social media influencer in the field of blood cancer.